(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical Studies

An inventory for assessing different kinds of hostility.

Buss, A. H., & Durkee, A. (1957) · Journal of Consulting Psychology · doi:10.1037/h0046900 · Cited by 2,614

Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings

McCann, U., Szabò, Z., Scheffel, U., Dannals, R. F., & Ricaurte, G. A. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04329-3 · Cited by 658

Serotonin function in anxiety

Charney, D. S., Woods, S. W., Goodman, W. K., & Heninger, G. R. (1987) · Psychopharmacology · doi:10.1007/bf00215473 · Cited by 462

Central Serotonin and Impulsive Aggression

Coccaro, E. F. (1989) · The British Journal of Psychiatry · doi:10.1192/s0007125000291769 · Cited by 451

Memory impairment in abstinent MDMA ("Ecstasy") users

Bolla, K. I., McCann, U. D., & Ricaurte, G. A. (1998) · Neurology · doi:10.1212/wnl.51.6.1532 · Cited by 374

Serotonergic Responsivity in Obsessive-Compulsive Disorder

Zohar, J. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800230026006 · Cited by 370

Ecstasy use in Australia: patterns of use and associated harm

Topp, L., Hando, J., Dillon, P., ROCHE, A. M., & Solowij, N. (1999) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00002-2 · Cited by 353

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance

Parrott, A. C., & Lasky, J. (1998) · Psychopharmacology · doi:10.1007/s002130050714 · Cited by 338

Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans

McCann, U. D., Ridenour, A., Shaham, Y., & Ricaurte, G. A. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.15 · Cited by 333

Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

McCann, U., Mertl, M., Eligulashvili, V., & Ricaurte, G. A. (1999) · Psychopharmacology · doi:10.1007/s002130050967 · Cited by 300

Effects of Acute 3, 4-Methylenedioxymethamphetamine on Sleep and Daytime Sleepiness in MDMA Users: A Preliminary Study

Randall, S., Johanson, C., Tancer, M. E., & Roehrs, T. (2009) · SLEEP · doi:10.1093/sleep/32.11.1513 · Cited by 20

High-performance liquid chromatography with electrochemical detection applied to the analysis of 3,4-dihydroxymethamphetamine in human plasma and urine

Segura, M., Ortuño, J., McLure, J. A., Pujadas, M., Pizarro, N., Farré, M., Llebaria, A., Joglar, J., Segura, J., & de la Torre, R. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00020-x · Cited by 20

Long-lasting behavioral sensitization to psychostimulants following p-chloroamphetamine-induced neurotoxicity in mice

Itzhak, Y., Achat‐Mendes, C., Ali, S. F., & Anderson, K. L. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00316-2 · Cited by 20

Effects of stress and MDMA on hippocampal gene expression

Weber, G. F., Johnson, B. N., Yamamoto, B. K., & Gudelsky, G. A. (2014) · BioMed Research International · doi:10.1155/2014/141396 · Cited by 19

Oxytocin, cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of recreational ‘ecstasy’

Parrott, A. C. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000262 · Cited by 21

Recreational 3,4-methylenedioxymethamphetamine or ‘ecstasy’: Current perspective and future research prospects

Parrott, A. C., Downey, L. A., Roberts, C. A., Montgomery, C., Bruno, R., & Fox, H. C. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117711922 · Cited by 19

Loud noise enhances nigrostriatal dopamine toxicity induced by MDMA in mice

Gesi, M., Ferrucci, M., Giusiani, M., Lenzi, P., Lazzeri, G., Alessandri, M., Salvadorini, A., Fulceri, F., Pellegrini, A., Fornai, F., et al. (2004) · Microscopy Research and Technique · doi:10.1002/jemt.20084 · Cited by 19

Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines

Heal, D. J., Gosden, J., Smith, S. L., & Atterwill, C. K. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109375 · Cited by 19

MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study

Raj, V., Liang, H., Woodward, N. D., Bauernfeind, A. L., Lee, J., Dietrich, M., Park, S., & Cowan, R. L. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109103203 · Cited by 18

Neurotoxicology and drug-related disorders

Weis, S., & Büttner, A. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00014-6 · Cited by 17

Attentional Processes in Abstinent Methylenedioxymethamphetamine (Ecstasy) Users

Zakzanis, K. K., Young, D. A., & Radkhoshnoud, N. F. (2002) · Applied Neuropsychology · doi:10.1207/s15324826an0902_3 · Cited by 17

Altered gene expression in frontal cortex and midbrain of 3,4‐methylenedioxymethamphetamine (MDMA) treated mice: Differential regulation of GABA transporter subtypes

Peng, W., & Simantov, R. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10571 · Cited by 17

Baclofen prevents MDMA-induced rise in core body temperature in rats

Bexis, S., Phillis, B. D., Ong, J. A., White, J. M., & Irvine, R. J. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.12.004 · Cited by 16

Fetal exposure to (±)-methylenedioxymethamphetamine in utero enhances the development and metabolism of serotonergic neurons in three-dimensional reaggregate tissue culture

Won, L., Bubula, N., & Heller, A. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00411-x · Cited by 16

Ecstasy during Loud Noise Exposure Induces Dramatic Ultrastructural Changes in the Heart

Gesi, M., Soldani, P., Lenzi, P., Ferrucci, M., Giusiani, A., Fornai, F., & Paparelli, A. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.910105.x · Cited by 16

Central Nervous System Alterations in Drug Abuse

Büttner, A., & Weis, S. (2004) · Forensic pathology reviews · doi:10.1007/978-1-59259-786-4_4 · Cited by 16

Differences Between Ecstasy-Using and Nonusing Methamphetamine Users

Brecht, M., & von Mayrhauser, C. (2002) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2002.10399956 · Cited by 16

Effects of a short-course MDMA binge on dopamine transporter binding and on levels of dopamine and its metabolites in adult male rats

Biezonski, D. K., Piper, B. J., Shinday, N. M., Kim, P. J., Ali, S. F., & Meyer, J. S. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.12.024 · Cited by 15

Gender differences in hyperthermia and regional 5-HT and 5-HIAA depletion in the brain following MDMA administration in rats

Wallinga, A. E., Grahlmann, C., Granneman, R. A., Koolhaas, J. M., & Buwalda, B. (2011) · Brain Research · doi:10.1016/j.brainres.2011.04.039 · Cited by 15

PRECLINICAL STUDY: Atypical development of behavioural sensitization to 3,4‐methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) in adolescent rats and its expression in adulthood: role of the MDMA chirality

Ameln, N. V., & von Ameln-Mayerhofer, A. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00187.x · Cited by 14

PET and SPECT in Drug and Substance Abuse

Mena, J. C., Cuellar, H., Vargas, D., & Riascos, R. (2005) · Topics in Magnetic Resonance Imaging · doi:10.1097/01.rmr.0000192177.01789.c0 · Cited by 14

MDMA Misrepresentation: An Unresolved Problem for Ecstasy Users

Hayner, G. N. (2002) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2002.10399953 · Cited by 14

Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing

Watkins, T. J., Raj, V., Lee, J., Dietrich, M. S., Cao, A., Blackford, J. U., Salomon, R. M., Park, S., Benningfield, M. M., Iorio, C., et al. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2936-1 · Cited by 13

Long-term ecstasy use and the management of work and relationships

Vervaeke, H., & Korf, D. J. (2006) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2006.09.002 · Cited by 13

MDMA Is Not Ecstasy: The Production of Pharmaceutical Safety through Documents in Clinical Trials

Hendy, K. (2019) · Medical Anthropology Quarterly · doi:10.1111/maq.12548 · Cited by 12

Serotonin in the Frontal Cortex: A Potential Therapeutic Target for Neurological Disorders

Lü, H., & Liu, Q.-S. (2017) · Biochemistry & Pharmacology Open Access · doi:10.4172/2167-0501.1000e184 · Cited by 10

Ecstasy (3,4-Methylenedioxymethamphetamine)-Induced Inappropriate Antidiuretic Hormone Secretion

Farah, R. E., & Farah, R. (2008) · Pediatric Emergency Care · doi:10.1097/pec.0b013e3181850c91 · Cited by 12

Rash-impulsivity, reward-drive and motivations to use ecstasy

Egan, S. T., Kambouropoulos, N., & Staiger, P. (2010) · Personality and Individual Differences · doi:10.1016/j.paid.2010.01.010 · Cited by 13

Effets aigus et à long terme de l’ecstasy

Salzmann, J., Cynthia Marie-claire, A., & Noble, F. (2004) · La Presse Médicale · doi:10.1016/s0755-4982(04)72379-9 · Cited by 12

Plasticity of the acoustic startle reflex in currently abstinent ecstasy (MDMA) users

Heekeren, K., Daumann, J., Geyer, M. A., & Gouzoulis‐Mayfrank, E. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1729-y · Cited by 11

Acute MDMA administration alters the distribution and circadian rhythm of wheel running activity in the rat

Ogeil, R. P., Rajaratnam, S. M. W., Redman, J. R., & Broadbear, J. H. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.094 · Cited by 11

Sleep, energy and self rated cognition across 7 nights following recreational ecstasy/MDMA use

Parrott, A. (2008) · Sleep and Hypnosis · Cited by 11

Effects of acute, subchronic and intermittent MDMA (‘ECSTASY’) administration on agonistic interactions between male mice

Navarro, J. F., & Maldonado, E. (2004) · Aggressive Behavior · doi:10.1002/ab.20004 · Cited by 11

Ecstasy intoxication: the toxicological basis for treatment

Ferigolo, M., Machado, A. G. D. S., Oliveira, N., & Barros, H. M. T. (2003) · Revista do Hospital das Clínicas · doi:10.1590/s0041-87812003000600008 · Cited by 9

MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: the contemporary human and animal research perspective

Parrott, A. C., & Marsden, C. A. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106063263 · Cited by 10

Ecstasy and sleep disturbance: Progress towards elucidating a role for the circadian system

Ogeil, R. P., Rajaratnam, S. M. W., & Broadbear, J. H. (2011) · Sleep and Biological Rhythms · doi:10.1111/j.1479-8425.2011.00510.x · Cited by 10

The intoxicated child

Solhkhah, R. (2003) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(03)00068-3 · Cited by 9

Morphological effects in the mouse myocardium after methylenedioxymethamphetamine administration combined with loud noise exposure

Gesi, M., Lenzi, P., Soldani, P., Ferrucci, M., Giusiani, A., Fornai, F., & Paparelli, A. (2002) · The Anatomical Record · doi:10.1002/ar.10084 · Cited by 8

New trends in drug addiction: the synthetic drugs. Epidemiological, clinical and preventive issues

Schifano, F. (2001) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00005121 · Cited by 7

Striatal Iron Deposition in Recreational MDMA (Ecstasy) Users

Coray, R. C., Berberat, J., Zimmermann, J., Seifritz, E., Stock, A., Beste, C., Cole, D. M., Unschuld, P. G., & Quednow, B. B. (2023) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2023.02.005 · Cited by 6

Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): Neurodegeneration versus Neuromodulation

Puerta, E., & Aguirre, N. (2011) · Pharmaceuticals · doi:10.3390/ph4070992 · Cited by 6

The Neuropathology of Drug Abuse

Büttner, A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00007-1 · Cited by 7

3,4-metilenodioximetanfetamina (‘éxtasis’): efectos emocionales y cognitivos a largo plazo y depleción serotoninérgica

Molero‐Chamizo, A. (2005) · Revista de Neurología · doi:10.33588/rn.4102.2004547 · Cited by 6

Dysfunctional overnight memory consolidation in ecstasy users

Smithies, V. G., Broadbear, J. H., Verdejo‐García, A., & Conduit, R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525673 · Cited by 5

Contribution of Impulsivity and Serotonin Receptor Neuroadaptations to the Development of an MDMA (‘Ecstasy’) Substance Use Disorder

Schenk, S., & Aronsen, D. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_421 · Cited by 4

Simulated Driving and Attention of Repeat Users of MDMA and THC Compared with THC Users and Non-Drug-Using Controls

Lamers, C. T. J., Rizzo, M., Bechara, A., & Ramaekers, J. G. (2006) · Transportation Research Record Journal of the Transportation Research Board · doi:10.1177/0361198106196900107 · Cited by 5

National Institute on Drug Abuse - ResearchReport

Torre, F. J., & Nyitray, K. J. (2005) · Cited by 5

MDMA induces Per1, Per2 and c-fos gene expression in rat suprachiasmatic nuclei

Ogeil, R. P., Kennaway, D. J., Salkeld, M. D., Rajaratnam, S. M. W., & Broadbear, J. H. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2541-8 · Cited by 4

Electroencephalographic and Convulsive Effects of Binge Doses of (+)- Methamphetamine, 5-methoxydiisopropyltryptamine, and (±)-3,4- Methylenedioxymethamphetamine in Rats

Graham, D. L. (2012) · The Open Neuropsychopharmacology Journal · doi:10.2174/1876523801205010001 · Cited by 4

MDMA – hopes and fears associated with therapeutic use in mental disorders

Kozera, K., Cichoń, L., Wilczyński, K. M., & Janas-Kozik, M. H. (2020) · Pharmacotherapy in Psychiatry and Neurology · doi:10.33450/fpn.2020.10.002 · Cited by 4

‘Ecstasy’ and the use of sleep medications in a general community sample: a 4‐year follow‐up

Tait, R. J., George, A. M., & Olesen, S. C. (2013) · Addiction · doi:10.1111/add.12200 · Cited by 4

Sleep deprivation enhances amyloid beta peptide, p-tau and serotonin in the brain: Neuroprotective effects of nanowired delivery of cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and serotonin

Sharma, A., Feng, L., Muresanu, D. F., Tian, Z. R., Lafuente, J. V., Buzoianu, A. D., Nozari, A., Bryukhovetskiy, I., Manzhulo, I., Wiklund, L., et al. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2023.05.009 · Cited by 3

How Psychoactive Drugs and the Circadian Clock Are Enlightening One Another

Engmann, O. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-81147-1_8 · Cited by 3

Recreational Drugs' Scenario and Compulsory Treatment in the United Kingdom

Schifano, F., & Tedeschi, D. (2008) · International Journal of Mental Health · doi:10.2753/imh0020-7411370302 · Cited by 3

Long-term neurobiological consequences of ecstasy: A role for pre-existing trait-like differences in brain monoaminergic functioning?

Wallinga, A. E., de Boer, S. F., Granneman, R. A., Koolhaas, J. M., & Buwalda, B. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.08.009 · Cited by 3

Disorders relating to the use of ecstasy and other ‘party drugs’

WINSTOCK, A. R., & Schifano, F. (2012) · doi:10.1093/med/9780199696758.003.0066 · Cited by 3

“Ecstasy”-induced neurotoxicity: the contribution of functional brain imaging

Schreckenberger, M. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1968-8 · Cited by 3

Molecular modeling of potential new and selective PET radiotracers for the serotonin transporter.

Wellsow, J., Kovar, K., & Machulla, H. (2002) · Cited by 3

Initiation de la consommation d'ecstasy chez les adolescents québécois à la fin du secondaire: Prédicteurs distaux et proximaux

Gagnon, V., Fallu, J., Brière, F. N., & Janosz, M. (2011) · The Canadian Journal of Psychiatry · doi:10.1177/070674371105600110 · Cited by 2

MDMA (3,4-methylenedioxy-methamphetamine)

Krishnan, J. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815223828124010004 · Cited by 1

Identification of an acetal derivative of the piperonyl methyl ketone in tablets seized for suspected drug trafficking

Amato, J., Iaccarino, N., Pagano, B., Maglieri, M., Persico, G., Russo, R., Caro, C. D., Calignano, A., Novellino, E., & Randazzo, A. (2014) · Forensic Toxicology · doi:10.1007/s11419-014-0236-7 · Cited by 1

Panic disorder due to ingestion of single dose ecstasy

Semiz, Ü. B., Başoğlu, C., Çetin, M., & Ebrinç, S. (2005) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500510028968 · Cited by 1

The Developing Brain as a Target for Experimental Treatments in Modeling Pathological Processes

Pankova, N. B., & Латанов, А. В. (2020) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-020-00936-9 · Cited by 1

Basic Substance Characteristics and Neuropathological Findings in Drug Abusers

Büttner, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-60531-5_4 · Cited by 1

Grundlegende Substanzmerkmale und neuropathologische Befunde bei Drogenkonsumenten

Büttner, A. (2022) · Springer eBooks · doi:10.1007/978-3-031-13619-1_4 · Cited by 1

Antidepressants, serotonin and cognition : applied and fundamental studies in human volunteers

Wingen, M. (2007) · Research Publications (Maastricht University) · doi:10.26481/dis.20070524mw · Cited by 1

Complicaciones físicas del consumo de drogas recreativas

Rodríguez, E. O., Martı́nez-Raga, J., Gómez, M. C., Gálvez, B. P., Ferragut, A. S., & Martínez, G. C. (2003) · Adicciones · doi:10.20882/adicciones.462 · Cited by 1

Update on the Ecstasy Epidemic

Gold, M. S., & Tabrah, H. (2000) · Journal of Addictions Nursing · doi:10.3109/10884600009041772 · Cited by 1

Editorial: Preface and Overview Second International MDMA ‘Ecstasy’ Conference in Australasia: Monash University, Melbourne, Australia

Broadbear, J. H. (2011) · The Open Addiction Journal · doi:10.2174/1874941001104010001 · Cited by 1

population based study childhood and use of MDMA: prospective, Symptoms of anxiety and depression in

Huizink, A. C., Ferdinand, R. F., van der Ende, J., & Verhulst, F. C. (2006) · Cited by 1

Mass Spectral and Chromatographic Studies on a Series Of Regioisomers and Isobaric Derivatives Related to Methylenedioxymethamphetamines

Awad, T. (2006)

Anatomical and Neurochemical Evidence of Neurotoxic Changes in Psychostimulant Abuse and Dependence

Sung, Y. H., & Renshaw, P. F. (2011) · Wiley eBooks · doi:10.1002/9781119998938.ch10

The Effects of Acute and Binge 3,4-methylenedioxymethamphetamine (MDMA) Exposure on Learning and Memory in Rats

Kay, C. J. (2010) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.16972807.v1

Substance Abuse: Drugs

Lukas, S. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397045-9.00098-7

Sobre o uso de ecstasy: uma pesquisa com vistas à formulação de intervenção preventiva

de Almeida, S. P. (2005) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.47.2005.tde-08022006-110827

ZAOSTŘENO NA DROG Y 4

Drogy, P. (2004)

Impulsivity, reward sensitivity and motivations to use ecstasy: an integrative study

Egan, S. T. (2006) · Swinburne figshare (Swinburne University of Technology) · doi:10.25916/sut.26263148

Immunhistochemische Untersuchung der cerebrovaskulären Basallamina mit Collagen Typ IV an Gehirnen von Drogentoten

Eisenmenger, W. (2007)

Assessment N>e Discriminative Stimulus Effects of (±)-3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and (+Lysergic Add Diethylamide (LSD) in a Three-Lever Drug Discrimination Procedure

Goodwin, A. (2002)

Oorspronkelijke stukken Korte- en langetermijneffecten van ecstasy op serotonineproducerende hersencellen en het geheugen*

Mc, T., Ig, P., Gc, B., & Jj, E. (2002)

Incidencia y percepción del mercado del Éxtasis, una mirada desde el neuromarketing

Avendaño, M. Á. P., Velasco, H. J. Q., & Delgado, F. E. R. (2017)

MDMA

Baucum, A. J., Clarke, Z., & Fleckenstein, A. E. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.62108-7

Amphetamine and Amphetamine Analogs

(2014) · John Wiley & Sons, Inc. eBooks · doi:10.1002/9781118850046.ch3

Substance abuse: drugs

Lukas, S. E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91497-0.00250-2

Utility of neuroimaging for substance misuse and addiction research: methodology, mechanisms, and therapeutics

Murnane, K. S., Derouen, A. G., Provenzano, D. A., Green, K. M., Williams, B. C., Samra, N. S., Cornett, E. M., & Kaye, A. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98814-8.00026-3

The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential

Brar, P. S., Price, R. B., Ross, S., Tofighi, B., & Sarpal, D. K. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261456191

The Role of Metabolism in Ecstasy-Mediated Serotonergic Neurotoxicity

Quezada, E., & Vanessa, G. (2009)

Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans

McCann, U. D., Ridenour, A., Shaham, Y., & Ricaurte, G. A. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.15 · Cited by 333

(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals

Ricaurte, G. A., Yuan, J., & McCann, U. D. (2000) · Neuropsychobiology · doi:10.1159/000026664 · Cited by 292

Toxicodynamics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’)

Ricaurte, G. A., McCann, U., Szabò, Z., & Scheffel, U. (2000) · Toxicology Letters · doi:10.1016/s0378-4274(99)00216-7 · Cited by 122

Toxic effect of MDMA on brain serotonin neurons

Klugman, A., Hardy, S., Baldeweg, T., & Gruzelier, J. H. (1999) · The Lancet · doi:10.1016/s0140-6736(05)66942-5 · Cited by 37

Neuroimaging of MDMA-Induced Neurotoxicity

McCann, U. D., Szabó, Z. R., & Ricaurte, G. A. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-165-7_18